Clinical trial / 2009
A Paleolithic diet improved glycemic control and cardiovascular risk markers in type 2 diabetes.
Thirteen patients with type 2 diabetes followed a Paleolithic diet and a standard diabetes diet for consecutive 3-month phases. Relative to the diabetes diet, the Paleolithic regimen produced lower mean HbA1c (-0.4% units, p = 0.01), triacylglycerols (-0.4 mmol/L, p = 0.003), and diastolic pressure (-4 mmHg, p = 0.03). It also reduced body mass by 3 kg (p = 0.01) while increasing HDL cholesterol by 0.08 mmol/L (p = 0.03).
- Study type
- Randomized crossover pilot study
- Who was studied
- 13 patients with type 2 diabetes
- What was measured
- Glycemic control, lipid profile, blood pressure, and anthropometric measures
THE PAPER
Beneficial effects of a Paleolithic diet on cardiovascular risk factors in type 2 diabetes: a randomized cross-over pilot study.
Jönsson T, Granfeldt Y, Ahrén B, Branell UC, Pålsson G, Hansson A, Söderström M, Lindeberg S. Cardiovasc Diabetol, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.